Skip to content

CHROMETRA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

CHROMETRA

BE 0643.522.447
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€22,351
2024 · €4,341-€26,693
Equity
€27,854
2024 · €50,206-€22,351
Cash
€8,906
2024 · €4,730+€4,176
Balance sheet total
€97,221
2024 · €74,834+€22,386

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€18,210

    up €18,210 (+26.0%), from €70,104 to €88,315

    of which Trade receivables: +€17,945

  • Cash +€4,176

    up €4,176 (+88.3%), from €4,730 to €8,906

    mainly Trade debts (+€37,099) and Other debts (+€7,639)

Equity and liabilities
  • Trade debts +€37,099

    up €37,099 (+241%), from €15,364 to €52,463

  • Profit (loss) carried forward -€22,351

    down €22,351 (-57.2%), from €39,046 to €16,694

  • Other debts +€7,639

    up €7,639 (+82.5%), from €9,265 to €16,903

Income statement
  • Gross operating margin -€28,780

    down €28,780, from €7,020 to -€21,760

  • Taxes -€1,441

    no longer reported in 2025 (was €1,441)

  • Other operating charges -€391

    down €391 (-45.7%), from €857 to €465

  • Depreciation -€266

    no longer reported in 2025 (was €266)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €4,341
Gross operating margin -€28,780
Depreciation +€266
Other operating charges +€391
Financial income +€3
Financial charges -€14
Taxes +€1,441
Result 2025 -€22,351
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€4,176
Investment €0
Financing €0
Cash 2024 €4,730
Net result for the year -€22,351
Receivables within one year -€18,210
Trade debts +€37,099
Other debts +€7,639
Cash 2025 €8,906
brings cash intakes cash out
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €74,834 €97,221 +€22,386 +29.9%
Current assets 29/58 €74,834 €97,221 +€22,386 +29.9%
Amounts receivable within one year 40/41 €70,104 €88,315 +€18,210 +26.0%
Trade receivables 40 €63,325 €81,271 +€17,945 +28.3%
Other amounts receivable 41 €6,779 €7,044 +€265 +3.9%
Cash at bank and in hand 54/58 €4,730 €8,906 +€4,176 +88.3%
Total equity and liabilities 10/49 €74,834 €97,221 +€22,386 +29.9%
Equity 10/15 €50,206 €27,854 -€22,351 -44.5%
Contributions 10/11 €11,160 €11,160 = 0.0%
Profit (loss) carried forward 14 €39,046 €16,694 -€22,351 -57.2%
Amounts payable 17/49 €24,629 €69,366 +€44,738 +182%
Amounts payable within one year 42/48 €24,629 €69,366 +€44,738 +182%
Trade debts 44 €15,364 €52,463 +€37,099 +241%
Suppliers 440/4 €15,364 €52,463 +€37,099 +241%
Other amounts payable 47/48 €9,265 €16,903 +€7,639 +82.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €266 - -€266
Other operating charges 640/8 €857 €465 -€391 -45.7%
Gross operating margin 9900 €7,020 -€21,760 -€28,780
Operating profit (loss) 9901 €5,897 -€22,226 -€28,122
Financial income 75/76B €0 €3 +€3 +1,595%
Recurring financial income 75 €0 €3 +€3 +1,595%
Financial charges 65/66B €115 €129 +€14 +12.5%
Recurring financial charges 65 €115 €129 +€14 +12.5%
Profit (loss) for the period before taxes 9903 €5,782 -€22,351 -€28,134
Income taxes 67/77 €1,441 - -€1,441
Profit (loss) for the period 9904 €4,341 -€22,351 -€26,693
Profit (loss) for the period to be appropriated 9905 €4,341 -€22,351 -€26,693

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.